ApoB gene polymorphism (rs676210) and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease
Abstract Background Drug response is below genetic influence, proven by the genetic variants. Pharmacogenetics trials are performed in many diseases, including coronary artery disease. This study was designed to determine the genetic polymorphism (rs676210) Pro2739leu G > A in the lipid metabolis...
Main Authors: | Shaimaa Y. Abdulfattah, Salwa J. Al-Awadi |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-06-01
|
Series: | Journal of Genetic Engineering and Biotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43141-021-00193-4 |
Similar Items
-
ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
by: Emanuel Voyiaziakis, et al.
Published: (1998-02-01) -
The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL
by: Jelena Vukmirica, et al.
Published: (2002-09-01) -
Effects of apoB-derived peptide vaccination in a murine model of systemic lupus erythematosus
by: Samuelsen, Brian
Published: (2016) -
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia
by: Jingshi Wu, et al.
Published: (1999-05-01) -
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
by: Kevin Yee-Bien Tse, et al.
Published: (2013-12-01)